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Background: Isopentenols, such as prenol and isoprenol, are promising advanced biofuels because of their higher
energy densities and better combustion efficiencies compared with ethanol. Microbial production of isopentenols
has been developed recently via metabolically engineered E. coli. However, current yields remain low and the
underlying pathways require systematic optimization.
Results: In this study, we targeted the E. coli native 2-methyl-(D)-erythritol-4-phosphate (MEP) pathway and its
upstream glycolysis pathway for the optimization of isopentenol production. Two codon optimized genes, nudF
and yhfR from Bacillus subtilis, were synthesized and expressed in E. coli W3110 to confer the isopentenol production
of the strain. Two key enzymes (IspG and Dxs) were then overexpressed to optimize the E. coli native MEP pathway,
which led to a significant increase (3.3-fold) in isopentenol production. Subsequently, the glycolysis pathway was
tuned to enhance the precursor and NADPH supplies for the MEP pathway by activating the pentose phosphate
pathway (PPP) and Entner-Doudoroff pathway (ED), which resulted in additional 1.9 folds of increase in isopentenol
production. A 5 L-scale batch cultivation experiment was finally implemented, showing a total of 61.9 mg L−1
isopentenol production from 20 g L−1 of glucose.
Conclusion: The isopentenol production was successfully increased through multi-step optimization of the MEP
and its upstream glycolysis pathways. It demonstrated that the total fluxes and their balance of the precursors
of the MEP pathway are of critical importance in isopentenol production. In the future, an elucidation of the
contribution of PPP and ED to MEP is needed for further optimization of isopentenol production.
Keywords: Isopentenol, MEP pathway, Entner-Doudoroff pathway, Pentose phosphate pathway (PPP), Escherichia
coli, Metabolic engineeringBackground
The growing global demand for energy, continuing con-
cerns about the environment and the increasing cost of
fossil fuels have called for the development of new forms
of energy [1,2]. The microbial production of bio-based
fuels and chemicals from biomass has recently become as
a promising, sustainable solution to this need [3,4]. Early
efforts in biofuel production have focused on improving
the yield of ethanol made from the fermentation of plant
sugars, and have shown a great success [5,6].* Correspondence: luting@illinois.edu
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unless otherwise stated.Recently, microbial production of advanced biofuels,
such as butanol and isobutanol, is being increasingly
explored due to the facts that advanced biofuels have
higher energy contents and, more importantly, are more
compatible with existing engines and fuel distribution
infrastructures [7-9]. One class of such advanced biofuels
is isopentenols, including prenol and isoprenol, which
have better combustion efficiencies than ethanol and
better octane numbers that are more similar to that of
gasoline compared with ethanol [10].
Isopentenol production using engineered microbes was
first reported in 2007 by Withers and co-workers [11].
Through the enrichment of a library of genomic DNA
from Bacillus subtilis, the authors discovered two genes
(yhfR and nudF) that encode enzymes that function di-
rectly on the prenyl diphosphate precursors, isopentenyl
pyrophosphate (IPP) and dimethylallyl pyrophosphateThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain

































Figure 1 The isopentenol biosynthesis pathway in engineered
E. coli. Pathway intermediates: G3P, glyceraldehyde-3-phosphate;
DXP, 1-deoxy-D-xylulose 5-phosphate; MEP, 2-C-methyl-D-erythritol
4-phosphate; CDP-ME, 4-diphosphocytidyl-2-C-methyl-D-erythritol;
CDP-MEP, 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate;
MECPP, 2-C-methyl-D-erythritol 2,4-cyclopyrophosphate; HMBPP,
1-hydroxy-2-methyl-2-(E)-butenyl 4-pyrophosphate; IPP, isopentenyl
pyrophosphate; DMAPP, dimethylallyl pyrophosphate; DHAP,
dihydroxyacetone 3-phosphate.
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Chou and Keasling reported another gene nudB which
encodes an enzyme capable of converting prenyl diphos-
phate precursors to isopentenols [10]. Overexpression of
these genes along with the introduction of a heterologous
mevalonate-dependent pathway (MVA) in E. coli has
resulted in successful isopentenol production [10-12].
In addition to the MVA pathway, the E. coli native
MEP pathway also holds the potential to be exploited
for isopentenol production. Indeed, several attempts
have been made for successful biosynthesis of other
forms of isoprenoids including taxadiene through the E.
coli native MEP pathway [13-15]. Up to date, reported
isopentenol production via the MVA pathway is much
higher than that via the MEP pathway. On the other
hand, there are advantages in using the MEP pathway:
According to the stoichiometry and redox balance ana-
lysis by a previous study [16], MEP is energetically more
balanced and theoretically more efficient than MVA in
converting sugars or glycerol to isoprenoid. In addition,
due to the inherent presence of the MEP pathway, it
requires fewer heterologous genes to be introduced.
We were therefore motivated in this work to increase
the isopentenol production of engineered E. coli by opti-
mizing its inherent MEP pathway (Figure 1). We first
synthesized two codon optimized genes, nudF and yhfR
from B. subtilis, and expressed them in our expression host
E. coli W3110 to confer its production of isopentenols
including both prenol and isoprenol. We then over-
expressed two key enzymes (IspG and Dxs) to optimize
the native E. coli MEP pathway, leading to a significant
increase in isopentenol titer. To further maximize the
isopentenol productivity, we enhanced the precursor
and NADPH supplies needed for the MEP pathway by
activating the pentose phosphate pathway (PPP) and
Entner-Doudoroff (ED) pathway through the disruption
of the E. coli phosphoglucose isomerase gene (pgi). To
evaluate the efficacy of our multi-step optimization of
isopentenol production, we finally implemented a 5 L-
scale laboratory batch fermentation using the optimal
strain identified.
Results and discussion
Expression of nudF and yhfR in E. coli W3110
To enable a successful isopentenol production in E. coli,
two genes, nudF and yhfR from Bacillus subtilis, were
identified as heterologous enzyme genes for direct con-
version of IPP and DMAPP into isoprenol and prenol
respectively. However, due to the different codon usages
of E. coli and B. subtilis, the codon adaption indexes
(CAI) of the wild-type yhfR (GeneBank: CP002906.1)
and nudF (GeneBank: CP003329.1) genes for the host
E. coli W3110 are only 0.31 and 0.25 respectively [17].
To address the potential low expression issue in theE. coli host, the ORF sequences of these two genes were
optimized to achieve a CAI of 1.0 for both (See Additional
file 1). The optimized yhfR and nudF genes were then
synthesized, ligated into the expression vector pACYC-
duet, and subsequently introduced into E. coli W3110
(DE3) for isopentenol production. GC analysis results
showed that, after 48 h of cultivation in M9 medium con-
taining yeast extract and glucose, the strain E. coli W3110
(DE3)/pACYC-yhfR produced a tiny amount of isoprenol
and prenol (<1 mg L−1) (Figure 2, EWIP1). In contrast, the
strain E. coli W3110 (DE3)/pACYC-nudF produced
2.6 mg L−1 prenol and 2.2 mg L−1 isoprenol (Figure 2,
EWIP2). No isoprenol or prenol production was detected
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duet (Figure 2, Control). These results supported the
earlier shown feasibility of producing isopentenol in
E. coli and also suggested that NudF is a more effective
enzyme than yhfR in isopentenol production.Optimization of MEP pathway for increased isopentenol
production
To elevate isopentenol production, the upstream MEP
pathway was targeted for optimization. In a recent study,
Zhou et al. showed that overexpression of the E. coli
HMBPP synthase gene (ispG) can increase the isopren-
oid production by reducing MECPP efflux, i.e., the rate
of MECPP transport out of the cell [18]. Based on this
finding, the ispG gene was cloned and ligated into
pACYC-nudF, resulting in a plasmid denoted as pACYC-
ispG-nudF. An overexpression experiment of the E. coli
W3110 (DE3)/pACYC-ispG-nudF showed that ispG
co-expression led to a 1.6-fold increase in isopentenol
production (Figure 2, EWIP 3).
Additionally, two recent studies have shown that over-
expression of the DXP synthase gene dxs is able to enhance
the metabolic flux of the MEP pathway and hence isopren-
oid production [19,20]. Encouraged by these results, we
further over-expressed the dxs gene along with ispG
and nudF in E. coli W3110 (DE3). Encouragingly, the
new strain resulted in an additional 2.1-fold increase in




























Figure 2 Isopentenol production by engineered E. coli strains.
A 250 mL-scale shaking flask containing 50 mL of semi-defined
medium, consisted of M9 minimum salts, 5 g L−1 yeast extract,
10 g L−1 glucose and 1 mM thiamine pyrophosphate (TPP), was
used for the cultivation of the strains. All strains are listed in Table 1.Tuning the glycolysis pathway to maximize the
isopentenol production
To further increase the isopentenol production of our
engineered strains, we traced back to the precursor
supplies of the MEP pathway and examined their roles
in influencing the overall isopentenol production.
As shown in the first step of MEP pathway in Figure 1,
one mole of deoxyxylulose-5-phosphate (DXP) is formed
from the equimolar condensation of glyceraldehyde-3-
phosphate (G3P) and pyruvate. This suggests that limita-
tions in G3P or pyruvate or their imbalance may reduce
DXP formation and hence hinder isopentenol production
[21]. In wild-type E. coli strains, glucose is metabolized
mainly through the Embden-Meyerhof-Parnas pathway
(~70%) and partially through Pentose Phosphate Pathway
(~30%) as depicted in Figure 3 (panel A). Both of the
pathways lack the control of pyruvate and G3P produc-
tions, which may imply an imbalanced G3P-pyruvate
ratio. Indeed, a couple of previous studies have supported
this speculation [22,23]: They showed that re-balancing
the pyruvate and G3P pools via the modification of the
EMP pathway can increase the isoprenoid production
significantly.
Meanwhile, there is an additional glycolytic pathway
responsible for glucose metabolism in E. coli–the Enter-
Doudoroff pathway [24,25]. The ED pathway is silent in
native E. coli strains consuming glucose but it is capable
of simultaneous production of pyruvate and G3P because
the pathway generates the two precursors concurrently
with a common cleavage reaction (Figure 3, panel B).
Therefore, compared with the EMP pathway, the ED
pathway is a potentially more appealing route for supply-
ing the precursors of the MEP pathway.
In addition, NADPH supply is another factor that
influences the efficiency of the MEP pathway. This is
because two moles of NADPH are needed in order to
produce one mole of isoprenoid unit (Figure 1). A recent
study has indeed proven that enhancing the carbon flux to
the PPP pathway, the major NADPH producing system in
E. coli, can increase isoprenoid production [26].
Taking into account both the precursor balance and
NADPH supply, we decided to shunt the glucose metabol-
ism from EMP to PPP and ED to maximize our isopentenol
production. To this end, we blocked the EMP by disrupting
the pgi gene in E. coli W3110, out of the reason that pgi
disruption can completely channel the glucose metabolic
flux to PPP (~90%) and ED (~10%) from EMP [27-29].
Shaking flask cultivation experiments showed that it signifi-
cantly increased the isopentenol production to 30.0 mg L−1
(Figure 2, EWIP5), 1.9 fold higher than the strain EWIP4.
We also replaced the native promoter of edd-eda
operon (eddp1) by a strong inducible Trc promoter in
E. coli W3110Δpgi (DE3) chromosome with the goal of

















































Figure 3 Thee glycolytic pathways present in E. coli. (A), The native EMP and PPP pathways are active in the E. coli strains EWIP1-4. (B) The
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Figure 4 Time course of isopentenol production, glucose
consumption and biomass formation of the engineered strain
E. coli EWIP5 during batch fermentation.
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glucose consumption and caused a decrease in isopente-
nol production (Figure 2, EWIP6). One possible reason is
the reduction of total NADPH production—two moles of
NADPH production from the PPP pathway compared
with one mole of NADPH via ED from one mole of
glucose. Future studies in the impacts of EMP blockage
and eddp1 replacement are needed for further optimization
of isopentenol production. In addition, a comprehensive
study on the alteration of metabolic flux upon EMP
blockage and eddp1 replacement will be also valuable
in order to elucidate the PPP and ED contributions to
MEP pathway and isopentenol production.
Lab-scale batch production of isopentenols
To evaluate the outcome of our multi-step optimization
of isopentenol production, a 5 L-scale laboratory batch
reactor was used for fermentation. Our most optimized
strain, EWIP5, was grown in 2 L M9 minimal salts medium
containing 5 g L−1 yeast extract and 20 g L−1 glucose. Our
fermentation results (Figure 4) showed that glucose was
completely consumed at hour 24 and 23.7 mg L−1 of prenol
and 16.2 mg L−1 of isoprenol were produced. However,
the prenol and isoprenol levels continued to increase
and reached 35.2 mg L−1 and 26.7 mg L−1 at hour 48. We
speculate that the additional isopentenol production after
glucose depletion was due to the consumption of yeast
extract and/or other secondary metabolites (such as acetic
acid) produced from glucose.
Conclusions
In this paper, we have successfully exploited the E. coli
native MEP pathway for the production of isopentenols
including prenol and isoprenol. We chose MEP instead
of MVA as the optimization target because the formeris more energetically balanced and theoretically more
efficient than the latter in converting sugars or glycerol
to isoprenoid according to the stoichiometry and redox
balance analysis [16]. To achieve our goal, multi-step
optimizations were employed to increase isopentenol
production: The expression of codon-optimized nudF
in E. coli W3110 led to the production of both isoprenol
and prenol; overexpression of the HMBPP synthase gene
ispG and DXP synthase gene dxs resulted in an additional
3.3-fold increase in isopentenols production; and shunting
the glycolysis from EMP to PPP and ED led to another
1.9-fold increase. Through the multi-step optimizations,
the resulting strain was able to produce isopentenols at a
level of 61.9 mg L−1.
It is also worthy to notice that the blocking of EMP to
channel glucose metabolism via PPP and ED explored
here provided a more balanced precursor pool for the
Table 1 Strains and plasmids used in this work
Plasmid/strain Function/characteristic Resource/reference
pACYC-yhfR yhfR expression vector This work
pACYC-nudF nudF expression vector This work
pACYC-ispG-nudF ispG and nudF co-expression vector This work
pACYC-dxs-ispG-nudF dxs, ispG and nudF co-expression vector ATCC No. 27325
W3110 E. coli W3110 F−, λ− IN (rrnD-rrnE)1 ATCC No. 27325
Δpgi E. coli W3110 Δpgi This work
Δpgi Δeddp1::pTrc E. coli W3110 Δpgi Δeddp1::pTrc This work
EWIP1 E. coli W3110 (DE3)/pACYC- yhfR This work
EWIP2 E. coli W3110 (DE3)/pACYC-nudF This work
EWIP3 E. coli W3110 (DE3)/pACYC-ispG-nudF This work
EWIP4 E. coli W3110 (DE3)/pACYC-dxs-ispG-nudF This work
EWIP5 E. coli W3110 (DE3) Δpgi/pACYC-dxs-ispG-nudF This work
EWIP6 E. coli W3110 (DE3) Δpgi Δeddp1::pTrc/pACYC-dxs-ispG-nudF This work
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cidate the exact contributions of PPP and ED to isopente-
nol production, this strategy may serve as a novel approach
for further optimization of MEP-dependent isoprenoid
biosynthesis. In the future, additional efforts, such as those
on precursor balance and NADPH supply, are also needed
for further improvement of the titer of isopentenols.
Methods
Strains and plasmids
All strains and plasmids used in this study are listed in
Table 1. E. coli W3110 was purchased from ATCC (No.
27325), whereas E. coli W3110 Δpgi was constructed by
deleting pgi gene in it. The pgi gene disruption cassette
was amplified with primers Pgi-KF and Pgi-KR (Table 2)















Pgi-R CGAAGAAGTTAGACAGCAGTpromoter was carried out using the cassette amplified with
primers Eddp1-KF and Eddp1-KR and pKD4 as template.
The plasmid pKD46 was used as the Red recombinase
expression vector while pCP20 was used to eliminate
the resistance gene. Gene disruption and resistant gene
elimination experiments were performed according to
the protocols obtained from OPENWETWARE [30].
To express the relevant genes under the control of the
T7 promoter, the 69734 λDE3 Lysogenization Kit
(Novagen, EMD Millipore, U.S.) was used to integrate
an λDE3 prophage into the E. coli host chromosome.
The codon adaption indices (CAI) of the B. subtilis yhfR
and nudF genes were analyzed using Optimizer [17]. The
codon-optimized sequences of yhfR and nudF were synthe-
sized and ligated into pACYCDuet-1 by NdeI and BglII to
construct pACYC-yhfR and pACYC-nudf, respectively. TheFunction
For PCR amplification of dxs
For PCR amplification of ispG
For PCR amplification of eddp1 replacement cassette
CTCCTT
CTTCG
For verification of eddp1 replacement with pTrc
TATCCTCCTTAGT For PCR amplification of pgi disruption cassette
TGGAGCTGCTTCG
For verification of pgi disruption
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using NcoI and BamHI, followed by further ligation of the
ispG with HindIII. The final plasmid was denoted as
pACYC-dxs-ispG-nudF. All primers used for the construc-
tion of plasmids are listed in Table 2.
Culture conditions
A 250 mL shaking flask containing 50 mL of semi-defined
medium, consisted of M9 minimum salts, 5 g L−1 yeast
extract, 10 g L−1 glucose and 1 mM thiamine pyrophosphate
(TPP), was utilized for the cultivation of the isopentenol
producing strains, chloramphenicol (35 mg mL−1) was also
added into the medium. The shaking flask was inoculated
with 1 mL of overnight culture and incubated with 150 rpm
agitation at 37°C. 0.5 mM Isopropyl ßD-1-thiogalactopyran-
oside (IPTG) was added when the optical density (OD600) of
the culture reached 0.3 AU. After IPTG addition, the culture
was transferred into 30°C shaking incubator (150 rpm) for
48 h of cultivation.
For fermenter scale isopentenol production, a 5 L la-
boratory reactor containing 2 L medium was used. The
2 L fermentation medium contained M9 minimum salts,
5 g L−1 yeast extract, 20 g L−1 glucose and 1 mM TPP.
Chloramphenicol was also added into the fermentation
medium at the same time. Inoculant was prepared by
introducing a single colony picked from an agar plate
into 5 mL of LB medium containing chloramphenicol.
The culture was grown at 37°C with 150 rpm agitation.
After 12 h, the culture was transferred to 100 mL fresh
LB medium containing chloramphenicol and was further
cultured for another 12 h. The inoculant was then trans-
ferred into the fermentation vessel to initiate the batch
fermentation (t = 0 h). When OD600 value reached 3.0 AU,
0.5 mM IPTG was added and the temperature was
decreased to 34°C. The agitation speed was controlled
by PID to maintain the dissolved oxygen (D.O.) at 20%
air saturation. Foaming was controlled by addition of
antifoam A whereas the pH was maintained at 7.0 by
addition of 2 N H2SO4 or NH4OH (28%).
Biomass analysis
Cellular growth was measured in terms of OD600. For
the calculation of biomass production, a standard curve
of dry cell weight was correlated with OD600. Samples
were collected in 2 mL pre-weighed pre-dried centrifuge
tubes and were pelleted at 8,000 g for 10 minutes. After
discarding the supernatant, the pellets were washed
twice with distilled water and dried at 105°C. One OD600
unit was equivalent to 0.29 g L−1 of dry cell weight.
Metabolite analysis
For glucose analysis, each culture sample was pelleted by
centrifugation and the collected supernatant was analyzed
in Waters HPLC equipped with a Bio-Rad Aminex HPX-87H Column (300 × 7.8 mm). The eluent (5 mM H2SO4)
was pumped at a flow rate of 0.4 mL min−1. The column
temperature was maintained at 55°C and the peaks were
detected using a Waters 2414 refractive index detector.
For isopentenol analysis, each sample was prepared by
ethyl acetate extraction and only the upper layer was
subject to GC analysis. The GC equipped with a flame
ionization detector (FID) and a CP-FFAP CB capillary
column (50 m × 0.25 mm; 0.2 μm film thickness) was
applied. The oven temperature was initially held at 50°C
for 1 min, then raised with a gradient of 5°C/min
until reaching 100°C, and finally programmed to 150°C at
25°C/min, then hold for 5 min. Nitrogen was used as the
carrier gas. The injector and detector were held at 250°C
and 270°C, respectively. This method can separate isopre-
nol and prenol efficiently, the isoprenol peak appeared at
13.9 min while the prenol peak appeared at 15.3 min.
Additional file
Additional file 1: Codon-optimized sequence of yhfR, Codon-
optimized sequence of nudF.
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